drugset / Trial / NCT06826040
SKB445 for Injection in Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB445 for injection in patients with advanced solid tumors.
Timeline
- Start
- 2025-02-05
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SKB445 | Unknown | — | — |